Korea Investment Corp’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
112,446
+80,300
+250% +$7.37M 0.02% 523
2025
Q4
$2.89M Hold
32,146
0.01% 632
2025
Q3
$3.17M Sell
32,146
-79,643
-71% -$7.89M 0.01% 624
2025
Q2
$10.2M Buy
111,789
+12,400
+12% +$1.2M 0.02% 496
2025
Q1
$11.2M Buy
99,389
+2,700
+3% +$289K 0.03% 481
2024
Q4
$10.2M Sell
96,689
-36,400
-27% -$3.91M 0.02% 522
2024
Q3
$14.4M Buy
133,089
+68,352
+106% +$7.46M 0.03% 407
2024
Q2
$7.03M Sell
64,737
-20,421
-24% -$2.41M 0.02% 518
2024
Q1
$11.2M Buy
85,158
+6,008
+8% +$750K 0.03% 439
2023
Q4
$9.63M Buy
79,150
+872
+1% +$97.3K 0.03% 473
2023
Q3
$8.78M Sell
78,278
-17,263
-18% -$2.19M 0.03% 427
2023
Q2
$13.9M Buy
95,541
+32,997
+53% +$4.48M 0.04% 369
2023
Q1
$8.08M Buy
62,544
+675
+1% +$84.7K 0.02% 445
2022
Q4
$7.89M Sell
61,869
-1,714
-3% -$199K 0.02% 471
2022
Q3
$6.65M Buy
63,583
+8,405
+15% +$922K 0.02% 494
2022
Q2
$5.8M Sell
55,178
-1,622
-3% -$192K 0.02% 530
2022
Q1
$7.26M Buy
56,800
+10,862
+24% +$1.31M 0.02% 505
2021
Q4
$5.67M Sell
45,938
-2,266
-5% -$297K 0.01% 494
2021
Q3
$6.85M Sell
48,204
-36,771
-43% -$5.41M 0.02% 439
2021
Q2
$13.3M Buy
84,975
+24,617
+41% +$3.99M 0.04% 336
2021
Q1
$9.38M Buy
60,358
+2,369
+4% +$367K 0.03% 388
2020
Q4
$8.68M Sell
57,989
-206
-0.4% -$29.1K 0.03% 385
2020
Q3
$7.69M Buy
58,195
+2,266
+4% +$296K 0.03% 369
2020
Q2
$6.48M Buy
55,929
+2,884
+5% +$332K 0.02% 395
2020
Q1
$5.21M Sell
53,045
-5,768
-10% -$756K 0.02% 399
2019
Q4
$8.55M Buy
58,813
+13,390
+29% +$1.85M 0.03% 387
2019
Q3
$6.05M Buy
45,423
+28,222
+164% +$3.65M 0.03% 425
2019
Q2
$1.97M Sell
17,201
-31,415
-65% -$3.68M 0.01% 532
2019
Q1
$6.03M Buy
48,616
+44,756
+1,159% +$5.09M 0.03% 436
2018
Q4
$389K Sell
3,860
-12,286
-76% -$1.38M ﹤0.01% 581
2018
Q3
$2.06M Sell
16,146
-4,853
-23% -$577K 0.01% 521
2018
Q2
$2.27M Sell
20,999
-117,935
-85% -$12.8M 0.01% 582
2018
Q1
$14.7M Sell
138,934
-4,503
-3% -$523K 0.07% 276
2017
Q4
$16.8M Buy
143,437
+16,080
+13% +$1.82M 0.08% 257
2017
Q3
$14.5M Sell
127,357
-175,306
-58% -$20.2M 0.07% 265
2017
Q2
$37.7M Buy
302,663
+31,983
+12% +$3.79M 0.18% 144
2017
Q1
$32.1M Buy
270,680
+212,212
+363% +$24.1M 0.16% 156
2016
Q4
$5.86M Buy
58,468
+20,637
+55% +$2.21M 0.03% 404
2016
Q3
$4.78M Buy
37,831
+23,926
+172% +$2.96M 0.03% 421
2016
Q2
$1.63M Buy
+13,905
New +$1.57M 0.01% 481
2016
Q1
Sell
-12,360
Closed -$1.23M 658
2015
Q4
$1.23M Sell
12,360
-98,159
-89% -$9.6M 0.01% 553
2015
Q3
$10.1M Buy
110,519
+22,557
+26% +$2.26M 0.08% 243
2015
Q2
$9.33M Buy
87,962
+32,239
+58% +$3.57M 0.08% 264
2015
Q1
$6.36M Buy
55,723
+31,415
+129% +$3.58M 0.05% 338
2014
Q4
$2.68M Sell
24,308
-3,708
-13% -$391K 0.02% 432
2014
Q3
$2.73M Sell
28,016
-36,565
-57% -$3.6M 0.02% 454
2014
Q2
$6.51M Buy
64,581
+13,081
+25% +$1.28M 0.05% 336
2014
Q1
$4.73M Buy
51,500
+27,604
+116% +$2.54M 0.04% 389
2013
Q4
$2.16M Sell
23,896
-26,368
-52% -$2.28M 0.02% 467
2013
Q3
$4.01M Sell
50,264
-21,321
-30% -$1.68M 0.04% 388
2013
Q2
$5.21M Buy
+71,585
New +$5.35M 0.06% 324

Other funds holding ZBH

Korea Investment Corp's ZBH Position: Q1 2026 in Review

Korea Investment Corp increased its Zimmer Biomet (ZBH) stake by 250% in Q1 2026, buying an estimated $7.37M and bringing the position to 112,446 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #523.

Korea Investment Corp first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $37.7M in Q2 2017. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Korea Investment Corp held 112,446 shares of Zimmer Biomet worth $10.2M as of Q1 2026.
  • Korea Investment Corp bought 80,300 Zimmer Biomet shares in Q1 2026, an estimated $7.37M.
  • Zimmer Biomet made up 0.02% of Korea Investment Corp's portfolio in Q1 2026, its #523 holding.
  • Korea Investment Corp first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
  • Korea Investment Corp's Zimmer Biomet position peaked at $37.7M in Q2 2017.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Korea Investment Corp's 13F filing for Q1 2026, filed 13 May 2026.